DE602007007697D1 - Verfahren zur Ermittlung von Arzneimittelempfindlichkeit durch Analyse von GIRK-Kanal-Genen - Google Patents

Verfahren zur Ermittlung von Arzneimittelempfindlichkeit durch Analyse von GIRK-Kanal-Genen

Info

Publication number
DE602007007697D1
DE602007007697D1 DE602007007697T DE602007007697T DE602007007697D1 DE 602007007697 D1 DE602007007697 D1 DE 602007007697D1 DE 602007007697 T DE602007007697 T DE 602007007697T DE 602007007697 T DE602007007697 T DE 602007007697T DE 602007007697 D1 DE602007007697 D1 DE 602007007697D1
Authority
DE
Germany
Prior art keywords
drug sensitivity
analysis
channel genes
girk channel
detecting drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602007007697T
Other languages
English (en)
Inventor
Kazutaka Ikeda
Masakazu Hayashida
Daisuke Nishizawa
Ichiro Sora
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tokyo Metropolitan Organization for Medical Research
Original Assignee
Tokyo Metropolitan Organization for Medical Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tokyo Metropolitan Organization for Medical Research filed Critical Tokyo Metropolitan Organization for Medical Research
Publication of DE602007007697D1 publication Critical patent/DE602007007697D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
DE602007007697T 2006-08-31 2007-08-31 Verfahren zur Ermittlung von Arzneimittelempfindlichkeit durch Analyse von GIRK-Kanal-Genen Active DE602007007697D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006235352 2006-08-31
JP2007221298A JP5308644B2 (ja) 2006-08-31 2007-08-28 Ｇｉｒｋチャネル遺伝子解析による薬物感受性の評価方法

Publications (1)

Publication Number Publication Date
DE602007007697D1 true DE602007007697D1 (de) 2010-08-26

Family

ID=38824985

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602007007697T Active DE602007007697D1 (de) 2006-08-31 2007-08-31 Verfahren zur Ermittlung von Arzneimittelempfindlichkeit durch Analyse von GIRK-Kanal-Genen

Country Status (5)

Country Link
US (1) US7858313B2 (de)
EP (1) EP1895016B1 (de)
JP (1) JP5308644B2 (de)
AT (1) ATE474067T1 (de)
DE (1) DE602007007697D1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6053267B2 (ja) * 2010-09-03 2016-12-27 公益財団法人東京都医学総合研究所 アドレナリン受容体遺伝子解析による薬物感受性および疾患脆弱性の評価方法
US9944985B2 (en) 2011-11-30 2018-04-17 Children's Hospital Medical Center Personalized pain management and anesthesia: preemptive risk identification and therapeutic decision support
CN102381970B (zh) * 2011-12-08 2014-01-15 南京优科生物医药有限公司 一种制备氟比洛芬酯化合物的方法
WO2013099808A1 (ja) * 2011-12-28 2013-07-04 公益財団法人東京都医学総合研究所 各種鎮痛関連遺伝子解析による薬物感受性の評価方法
CA2940422A1 (en) 2014-02-24 2015-08-27 Children's Hospital Medical Center Methods and compositions for personalized pain management
EP3571309A4 (de) 2017-01-20 2020-11-25 Children's Hospital Medical Center Verfahren und zusammensetzungen in bezug auf die oprm1-dns-methylierung für personalisiertes schmerzmanagement
CN108962339A (zh) * 2018-06-11 2018-12-07 山东中医药大学附属医院 基因多态性与血脂水平的关联性对照方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003000258A (ja) * 2001-06-13 2003-01-07 Inst Of Physical & Chemical Res 薬物感受性の評価方法
US20040214324A1 (en) * 2002-12-09 2004-10-28 Ole Isacson Dopaminergic neurons differentiated from embryonic cells for treating neurodegenerative diseases
US20050287574A1 (en) * 2004-06-23 2005-12-29 Medtronic, Inc. Genetic diagnostic method for SCD risk stratification
CA2644475A1 (en) * 2006-03-01 2007-09-07 Perlegen Sciences, Inc. Markers for addiction
US20080248470A1 (en) * 2007-04-04 2008-10-09 Sungkyunkwan University Foundation For Corporate Collaboration Genetic screening for predicting antidepressant drug response based on the monoamine transporter gene polymorphism combination

Also Published As

Publication number Publication date
ATE474067T1 (de) 2010-07-15
US7858313B2 (en) 2010-12-28
JP2008079607A (ja) 2008-04-10
US20090092972A1 (en) 2009-04-09
JP5308644B2 (ja) 2013-10-09
EP1895016A1 (de) 2008-03-05
EP1895016B1 (de) 2010-07-14

Similar Documents

Publication Publication Date Title
DE602007007697D1 (de) Verfahren zur Ermittlung von Arzneimittelempfindlichkeit durch Analyse von GIRK-Kanal-Genen
NO20083957L (no) DNA-konformasjon
ATE544063T1 (de) Nanoporenvorrichtung und verfahren zur nukleinsäureanalyse
DE602007003165D1 (de) Verfahren und Systeme zur Definition, Identifikation und Erfassung geometrischer Eigenschaften
ATE555214T1 (de) Verfahren zur diagnose proliferativer erkrankungen durch detektion von genmethylierung
EP2321430B8 (de) Verfahren zur bewertung des oralkarzinomrisikos bei menschen
BRPI0811503A2 (pt) Diagnótico de melanoma por análise de ácido nucleico
BRPI0715346A2 (pt) Detecção de analitos e ácidos nucléicos
DE602007008953D1 (de) Qpcr unter verwendung eines ionen-sensitiven feldeffekt-transistors zur ph-messung
DK2620510T4 (da) Enkeltmolekyle-arrays til genetisk og kemisk analyse
DK3178559T3 (da) Integreret indretning til at udføre ekstraktion af nukleinsyre og diagnosetest på flere biologiske prøver
DK2258871T3 (da) Fremgangsmåder og nukleinsyrer til analyse af celleproliferative lidelser
WO2008148072A3 (en) Disease-associated genetic variations and methods for obtaining and using same
BRPI0520067A2 (pt) desenvolvimento de um ensaio de pcr em tempo real para a detecção de dna pneumocócico e diagnóstico da doença pneumocócica
WO2007133682A3 (en) 100% sequence identity detection methods for variable genomes
FR2897873B1 (fr) Procede d'analyse microbiologique rapide.
WO2008122670A3 (en) Human diabetes susceptibility tnfrsf10b gene
EP2075341A4 (de) Verfahren zur untersuchung, bestimmung oder bewertung mittels genexpressionsanalyse
HK1133295A1 (en) Use of protein s100a12 as a marker for colorectal cancer s100a12
WO2008076856A3 (en) Reagents and methods for detecting cyp2d6 polymorphisms
WO2005124356A3 (en) Use of protein cbp2 as a marker for colorectal cancer
WO2008065682A3 (en) Genetic susceptibility variants of type 2 diabetes mellitus
WO2009007649A3 (fr) Dispositif et procede d'identification et de determination de groupes sanguins
ATE555197T1 (de) Verfahren zur evaluierung der wirkstoffsensitivität mittels analyse des pomc- gens
EP2354228A8 (de) Auf interferontherapie ansprechender identifizierungsmarker für nierenzellkrebs

Legal Events

Date Code Title Description
R082 Change of representative

Ref document number: 1895016

Country of ref document: EP

Representative=s name: HOFFMANN - EITLE, 81925 MUENCHEN, DE